Cardiovascular Adverse Events After Aortic Valve Replacement in Mixed Aortic Valve Disease Beyond Ejection Fraction

There are limited data about outcomes after aortic valve replacement (AVR) in patients with mixed aortic valve disease (MAVD) (1). We conducted a retrospective review of all adults with moderate-to-severe MAVD who underwent AVR at Mayo Clinic from January 1, 1994 to December 31, 2014 to determine the occurrence of cardiovascular adverse events (CAE). Moderate-to-severe MAVD was defined as the combination of greater than or moderate aortic stenosis and greater than or moderate aortic regurgitation.

http://ift.tt/2g1xGyl